Wilson Sonsini Goodrich & Rosati advised Foresight Diagnostics on the transaction. Allogene Therapeutics Inc. (Nasdaq: ALLO) and Foresight Diagnostics, announced a strategic partnership to develop a minimal residual...
Foresight Diagnostics’ Partnership with Allogene Therapeutics
Arcellx’s Expansion of Partnership with Kite
Wilson Sonsini Goodrich & Rosati is advising Arcellx on the transaction. Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD) announced that they have...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Cyclo Therapeutics’ Acquisition of Applied Molecular Transport
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
Foresight Diagnostics’ $58.75 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
EVERY’s $175 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised EVERY on the deal while Pillsbury Winthrop Shaw Pittman represented McWin. The EVERY Company, the leading precision fermentation platform accelerating a...
Hexagon Bio’s $61 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the deal. Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome,...
80 Acres Farms’ $160 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Siemens Financial Services, Inc. on the deal. Acres Farms, an industry-leading vertical farming company, secured $160 million in additional funding...
Day One Biopharmaceuticals’ IPO
Wilson Sonsini Goodrich & Rosati and Fenwick & West LLP advised Day One Biopharmaceuticals on the deal. San Francisco-based Day One Biopharmaceuticals, a Phase 2 biotech...
Applied Molecular Transport’s $105 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...
Day One Biopharmaceuticals’ $130 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Day One Biopharmaceuticals on the deal. Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies...